-

The Estée Lauder Companies to Webcast Discussion of Fiscal 2025 Second Quarter Results on February 4, 2025

NEW YORK--(BUSINESS WIRE)--The Estée Lauder Companies Inc. (NYSE: EL) will release its fiscal 2025 second quarter results on February 4, 2025.

On that date, at 8:30 a.m. (ET), the Company will provide a live webcast of its conference call and presentation discussing the results, future prospects and recent corporate developments. Stéphane de La Faverie, President and CEO, and Akhil Shrivastava, EVP and CFO, will host the call.

Those wishing to access the webcast can visit http://www.elcompanies.com/investors. The call will be archived on the Company’s website.

PLEASE NOTE: This call, and all calls going forward, will start an hour earlier than usual at 8:30 am (ET).

The Estée Lauder Companies Inc. is one of the world’s leading manufacturers, marketers and sellers of quality skin care, makeup, fragrance and hair care products, and is a steward of luxury and prestige brands globally. The Company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, M·A·C, La Mer, Bobbi Brown Cosmetics, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, Too Faced, Dr.Jart+, the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty.

ELC-F

Contacts

Investors: Rainey Mancini
rmancini@estee.com

Media: Jill Marvin
jimarvin@estee.com

The Estée Lauder Companies Inc.

NYSE:EL

Release Versions

Contacts

Investors: Rainey Mancini
rmancini@estee.com

Media: Jill Marvin
jimarvin@estee.com

More News From The Estée Lauder Companies Inc.

The Estée Lauder Companies Partners with Serpin Pharma, Inc to Develop Breakthrough Skin Care Ingredients to Advance Longevity

NEW YORK--(BUSINESS WIRE)--The Estée Lauder Companies Inc. (NYSE: EL) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory research can be applied in cosmetics to deliver significant skin care longevity benefits to consumers around the world. The exclusive partnership will accelerate ELC’s focus on transformative product innovation by applying insights from Serpin Pharma’s two decades of anti-inflammatory research, whi...

Stéphane de La Faverie Announces Leadership Updates in Support of The Estée Lauder Companies’ Beauty Reimagined Vision

NEW YORK--(BUSINESS WIRE)--Stéphane de La Faverie, President and CEO of The Estée Lauder Companies today announced the Company’s new organizational structure and Executive Team, to lead the Beauty Reimagined vision and action plan to be the best consumer-centric prestige beauty company in the world, and restore sales growth and stronger profitability. “Earlier today, I announced Beauty Reimagined, our bold strategic vision for the future of our incredible Company,” said Stéphane. “To deliver ou...

The Estée Lauder Companies Reports Fiscal 2025 Second Quarter Results

NEW YORK--(BUSINESS WIRE)--The Estée Lauder Companies Inc. (NYSE: EL) today launched Beauty Reimagined, its new strategic vision, and reported its financial results for the second quarter ended December 31, 2024. “Today, we are excited to launch Beauty Reimagined, a bold strategic vision to restore sustainable sales growth and achieve a solid double-digit adjusted operating margin over the next few years as we aim to become the best consumer-centric prestige beauty company,” said Stéphane de La...
Back to Newsroom
  1. There was an issue with the authorization server. Please contact support if the issue persists.